← Back to Search

Value Champion Training for Dementia

N/A
Waitlist Available
Led By Lorella Palazzo, PhD
Research Sponsored by Kaiser Permanente
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will test whether training a clinician to be a 'value champion' can decrease the use of three classes of potentially inappropriate prescription medications among people living with dementia.

Eligible Conditions
  • Dementia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Medication Possession Ratio for any medication in these three classes: antipsychotics, benzodiazepines, or hypoglycemic medication (sulfonylureas or insulin).
Secondary outcome measures
Number of Emergency Department or Hospitalizations attributed to a fall.
Number of equity related milestones achieved by each clinician champion during their project. Recorded in the Value Champions Project Workbook.
Number of milestones completed by the clinician champions during the "design and implement" phase of their improvement project- recorded in the Value Champions Project Workbook
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Value Champion Training ProgramExperimental Treatment1 Intervention
Intervention arm.
Group II: Standard CareActive Control1 Intervention
Control group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Value Champion Training Program
2023
N/A
~2150

Find a Location

Who is running the clinical trial?

Brown UniversityOTHER
456 Previous Clinical Trials
556,109 Total Patients Enrolled
19 Trials studying Dementia
206,172 Patients Enrolled for Dementia
Kaiser PermanenteLead Sponsor
541 Previous Clinical Trials
23,904,969 Total Patients Enrolled
10 Trials studying Dementia
195,704 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,693 Previous Clinical Trials
28,025,111 Total Patients Enrolled
275 Trials studying Dementia
23,626,255 Patients Enrolled for Dementia

Media Library

Value Champion Training Program Clinical Trial Eligibility Overview. Trial Name: NCT05359679 — N/A
Dementia Research Study Groups: Value Champion Training Program, Standard Care
Dementia Clinical Trial 2023: Value Champion Training Program Highlights & Side Effects. Trial Name: NCT05359679 — N/A
Value Champion Training Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05359679 — N/A
~1227 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top